Instytut Hematologii I Transfuzjologii — Clinical Trial Site

81 Registered trials

31 Currently recruiting

Organisation

Instytut Hematologii I Transfuzjologii

Location

Warsaw, Poland

Identifier

ORG-100032214

Address

Ul. Indiry Gandhi 14, 02-776, Poland

Departments

-
2106: Klinika Hematologii
2140: Klinika Hematologii
2801: Klinika Hematologii
2802 : Klinika Hematologii, Onkologiczne Centrum Wsparcia Badań Klinicznych
CWBK/Klinika Hematologii z Poradnią Hematologii
Haematology
Hematology
Instytut Hematologii i Transfuzjologii
Instytut Hematologii i Transfuzjologii-SZPITAL W WARSZAWIE, Klinika Hematologii
Klinika Hematologi
Klinika Hematologii
Klinika Hematologii i Oddział Badań Klinicznych
Klinika Hematologii oraz oddział badań klinicznych
Klinika Hematologii oraz Poradnia Hematologiczna
Klinika Hematologii, Klinika Hematologii i Transfuzjologii
Klinika Hematologii, Klinika Hematologii i Transfuzjologii
Klinika Hematologii, Poradnia Hematologiczna
Klinika Hematologii; Onkologiczne Centrum Wsparcia Badań Klinicznych
Klinika Transplantacji Komórek IHiT
Klinika Transplantacji Komórek Krwiotwórczych
Klinika Zaburzeń Hemostazy i Chorób Wewnętrznyc
Klinika Zaburzeń Hemostazy i Chorób Wewnętrznych
Klinika Zaburzeń Hemostazy i Chorób Wewnętrznych Instytutu Hematologii i Transfuzjologii w Warszawie
N/A

Clinical trials at this site (81)

Search interface

A Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel versus Bortezomib, Len… Ended

2023-505850-16-00 Multiple Myeloma 5 2021-08-05
A Phase 3 Open Label, Randomized Study of LOXO 305 versus Investigator's Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab … Ended

2023-507697-40-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2021-07-05
A Phase 3 study of Tafasitamab plus Lenalidomide in addition to Rituximab, versus Lenalidomide plus Rituximab in patients With Relapsed/Refr… Ended

2023-504684-16-00 follicular lymphoma (FL) and marginal zone lymphoma (MZ 5 2021-06-05
A Study to Evaluate the Efficacy and Safety of Glofitamab in Combination with Gemcitabine Plus Oxaliplatin Versus Rituximab in Combination w… Ended

2023-506899-27-00 Relapsed or refractory diffuse large B-cell lymphoma 5 2021-03-25
A Combination of Acalabrutinib with R-CHOP in Subjects with previously untreated non-GCB DLBCL Ended

2023-509358-72-00 Diffuse large B-cell lymphoma 5 2020-11-23
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Ended

2022-501522-38-00 Chronic lymphocytic leukemia; Non-Hodgkin's lymphoma; M 5 2020-09-04
PACIFICA: A Phase 3 Study of Pacritinib in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thro… Ended

2024-515953-52-00 Post-Essential Thrombocythaemia Myelofibrosis 5 2020-07-24
A Randomized Study Comparing JNJ-68284528 versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexametha… Ended

2023-506588-32-00 Relapsed and Lenalidomide-Refractory Multiple Myeloma 5 2020-06-12
Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell … Ended

2023-509908-15-00 Mantle Cell Lymphoma 10 2020-01-20
Research study to look at how well the drug Concizumab works in your body if you have haemophilia without inhibitors Ended

2023-506831-13-00 haemophilia A (HA) without inhibitors and haemophilia B 5 2020-01-15
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previo… Ended

2024-511747-25-00 B-cell non-Hodgkin lymphoma (NHL) 4 2019-12-23
Research study to comparison the effectivenes of combination of drugs called lenalidomide, carfilzomib, dexamethasone with combination of dr… Ended

2024-518473-34-00 Multiple Myeloma 5 2019-11-20
Research study to look at how well the drug concizumab works in your body if you have haemophilia with inhibitors Ended

2023-506832-33-00 haemophilia A (HA) with inhibitors and haemophilia B (H 5 2019-11-06
A Randomized, Open-label, Phase 3 study of the Combination of Ibrutinib plus Venetoclax versus Chlorambucil plus Obinutuzumab for the First-… Ended

2023-503469-49-00 Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic L 5 2018-04-19
A Phase 3 study to test the AG-120 in combination with Azacitidine in comparison with the use of Azacitidine alone in patients ≥ 18 Years of… Ended

2024-514309-73-00 Previously Untreated Acute Myeloid Leukemia with an IDH 5 2018-02-06
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination wi… Ended

2023-509354-58-00 Mantle Cell Lymphoma 5 2017-07-14
Application of antiCD19 CAR T lymphocytes for the treatment of adult patients with B-cell acute lymphoblastic leukemia with resistance, rela… Halted

2024-519808-27-00 B-cell acute lymphoblastic leukemia. with resistance, r 7 2023-12-19
A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myelo… Ended

2023-505910-10-00 Relapsed or Refractory High-Risk Myelodysplastic Syndro 4 2024-01-23
APTIVATE Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients with… Ended

2023-503244-14-00 Relapsed or Refractory Acute Myeloid Leukemia (AML) 7 2023-08-11
A Phase 2b study of TAK-755 (rADAMTS13) with minimal to no plasma exchange in the treatment of patients with thrombotic thrombocytopenic Pur… Ended

2023-507787-39-00 Immune-mediated thrombotic thrombocytopenic purpura (iT 4 2023-04-27
A clinical study conducted to evaluate the safety, efficacy and tolerability of a drug called liposomal annamycin administered with cytarabi… Ended

2024-516388-10-00 Acute Myeloid Leukemia 9 2022-09-23
Asciminib treatment optimization in ≥ 3rd line CML-CP Ended

2024-511381-36-00 Chronic Myelogenous Leukemia in chronic phase (CML-CP) 5 2021-10-13
Efficacy and safety of obinutuzumab versus rituximab in combination with chemotherapy for adult patients with newly diagnosed CD20-positive … Ended

2024-517389-40-00 acute lymphoblastic leukemia 4 2021-10-06
A continuation study to evaluate the prophylactic and on demand treatment of congenital Thrombotic Thrombocytopenic Purpura (cTTP) with the … Ended

2024-513839-24-00 Congenital Thrombotic thrombocytopenic purpura (cTTP) 5 2021-09-07